ObvioHealth
12
0
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Goat or Cow Milk Based Infant Formula GMS
Role: collaborator
Early Allergen System Experience
Role: collaborator
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
Role: collaborator
Growth and Safety Clinical Trial on a New Infant Formula
Role: collaborator
Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic
Role: collaborator
A COVID-19 Symptom, Exposure and Immune Response Registry
Role: lead
Lumenato Nutritional Supplement on Skin Appearance
Role: collaborator
Study of Stool Patterns to Collect a Panel of Stool Images for the Development of a Software
Role: collaborator
A Clinical Study Assessing Efficacy of an Herbal Blend on Menopausal Symptoms and Quality of Life
Role: collaborator
Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
Role: collaborator
Rice Vinegar as an Intervention to Lower Blood Pressure in Adults With Prehypertension and 10-year CVD Risk <10%
Role: collaborator
An In-home Observational Study to Compare Infant Crying and Fussing Parameters Documented by the LENA Recorder With Those Documented Via Parental E-diaries
Role: collaborator
All 12 trials loaded